Company Filing History:
Years Active: 2024
Title: Marie-Laure Nevoret: Innovator in Mucopolysaccharidosis Treatment
Introduction
Marie-Laure Nevoret is a prominent inventor based in Virginia Beach, VA (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of rare genetic disorders. Her innovative work focuses on developing therapies that improve the quality of life for patients diagnosed with mucopolysaccharidosis II (MPS II).
Latest Patents
Marie-Laure Nevoret holds a patent for the "Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)." This patent describes compositions and methods for delivering recombinant human iduronate-2-sulfatase (IDS) produced by human neuronal or glial cells to the cerebrospinal fluid of the central nervous system (CNS) of a human subject diagnosed with MPS II. She has 1 patent to her name, showcasing her dedication to advancing medical science.
Career Highlights
Marie-Laure is associated with Regenxbio Inc., a company known for its innovative gene therapy solutions. Her work at Regenxbio has positioned her as a key player in the development of treatments for genetic disorders. Her research has the potential to transform the lives of individuals affected by MPS II.
Collaborations
Marie-Laure has collaborated with notable professionals in her field, including Stephen Joseph Pakola and Paulo Falabella. These partnerships have enhanced her research and contributed to the advancement of therapeutic strategies for genetic diseases.
Conclusion
Marie-Laure Nevoret is a trailblazer in the field of biotechnology, with a focus on treating mucopolysaccharidosis II. Her innovative patent and work at Regenxbio Inc. highlight her commitment to improving patient outcomes. Her contributions to medical science are invaluable and continue to inspire future advancements in the field.